TermID	Term	Enrichment	logP	Genes in Term	Target Genes in Term	Fraction of Targets in Term	Total Target Genes	Total Genes	Entrez Gene IDs	Gene Symbols
WP2853	Endoderm Differentiation	0.0102344838924474	-4.58199248689044	145	3	0.176470588235294	17	5311	5083,23007,79776	PAX9,PLCH1,ZFHX4
WP2485	NAD Biosynthesis II (from tryptophan)	0.0253386938721314	-3.67542264953237	8	1	0.0588235294117647	17	5311	8942	KYNU
WP3593	miR-148a/miR-31/FIH1/HIF1&alpha;-Notch signaling in glioblastoma	0.0284631973990626	-3.55914334550993	9	1	0.0588235294117647	17	5311	23462	HEY1
WP15	Selenium Micronutrient Network	0.0307596473183804	-3.48155160000274	87	2	0.117647058823529	17	5311	6289,8942	SAA2,KYNU
WP1425	Bone Morphogenic Protein (BMP) Signalling and Regulation	0.0377802412006221	-3.27596903258235	12	1	0.0588235294117647	17	5311	658	BMPR1B
WP615	Senescence and Autophagy in Cancer	0.0441625846122152	-3.11987735036969	106	2	0.117647058823529	17	5311	1029,9547	CDKN2A,CXCL14
WP1742	TP53 Network	0.0622162634113573	-2.77713884377826	20	1	0.0588235294117647	17	5311	1029	CDKN2A
WP2884	NRF2 pathway	0.0752117753210835	-2.58744747356823	143	2	0.117647058823529	17	5311	2042,55117	EPHA3,SLC6A15
WP2858	Ectoderm Differentiation	0.0752117753210835	-2.58744747356823	143	2	0.117647058823529	17	5311	60401,79776	EDA2R,ZFHX4
WP205	IL-7 Signaling Pathway	0.0771908988002348	-2.56147372008979	25	1	0.0588235294117647	17	5311	3574	IL7
WP2895	Differentiation of white and brown adipocyte	0.0771908988002348	-2.56147372008979	25	1	0.0588235294117647	17	5311	7545	ZIC1
WP530	Cytokines and Inflammatory Response	0.0801586919759184	-2.52374695944441	26	1	0.0588235294117647	17	5311	3574	IL7
WP3845	Canonical  and Non-canonical Notch signaling	0.0831175003453329	-2.48750000548584	27	1	0.0588235294117647	17	5311	23462	HEY1
WP2857	Mesodermal Commitment Pathway	0.0874270488849675	-2.43695056039119	156	2	0.117647058823529	17	5311	79776,23007	ZFHX4,PLCH1
WP34	Ovarian Infertility Genes	0.0977776604693748	-2.32505914859185	32	1	0.0588235294117647	17	5311	658	BMPR1B
WP3893	Development and heterogeneity of the ILC family	0.0977776604693748	-2.32505914859185	32	1	0.0588235294117647	17	5311	3574	IL7
WP2828	Bladder Cancer	0.0977776604693748	-2.32505914859185	32	1	0.0588235294117647	17	5311	1029	CDKN2A
WP2636	Common Pathways Underlying Drug Addiction	0.126438633411058	-2.06799819989419	42	1	0.0588235294117647	17	5311	2891	GRIA2
WP465	Tryptophan metabolism	0.137661267963838	-1.98295919121721	46	1	0.0588235294117647	17	5311	8942	KYNU
WP1591	Heart Development	0.137661267963838	-1.98295919121721	46	1	0.0588235294117647	17	5311	23462	HEY1
WP2848	Differentiation Pathway	0.143221563947397	-1.94336244956772	48	1	0.0588235294117647	17	5311	10468	FST
WP3611	Photodynamic therapy-induced AP-1 survival signaling.	0.151498775111969	-1.88717773913491	51	1	0.0588235294117647	17	5311	1029	CDKN2A
WP1533	Vitamin B12 Metabolism	0.156975040593086	-1.85166846338613	53	1	0.0588235294117647	17	5311	6289	SAA2
WP2272	Pathogenic Escherichia coli infection	0.162418028434082	-1.81758184489086	55	1	0.0588235294117647	17	5311	9076	CLDN1
WP560	TGF-beta Receptor Signaling	0.170520529195523	-1.76889958366792	58	1	0.0588235294117647	17	5311	10468	FST
WP61	Notch Signaling Pathway	0.181209153434392	-1.70810337100679	62	1	0.0588235294117647	17	5311	23462	HEY1
WP45	G1 to S cell cycle control	0.196999309259545	-1.62455505654702	68	1	0.0588235294117647	17	5311	1029	CDKN2A
WP176	Folate Metabolism	0.199602973524231	-1.61142501779975	69	1	0.0588235294117647	17	5311	6289	SAA2
WP2572	Primary Focal Segmental Glomerulosclerosis FSGS	0.212502542540246	-1.54880132579397	74	1	0.0588235294117647	17	5311	9076	CLDN1
WP2261	Signaling Pathways in Glioblastoma	0.235230095593545	-1.44719111368797	83	1	0.0588235294117647	17	5311	1029	CDKN2A
WP254	Apoptosis	0.242667736991763	-1.41606210878295	86	1	0.0588235294117647	17	5311	1029	CDKN2A
WP1772	Apoptosis Modulation and Signaling	0.262170015214497	-1.33876207264163	94	1	0.0588235294117647	17	5311	1029	CDKN2A
WP2064	Neural Crest Differentiation	0.281198907739466	-1.26869300333672	102	1	0.0588235294117647	17	5311	7545	ZIC1
WP179	Cell Cycle	0.288214907094992	-1.24404887192792	105	1	0.0588235294117647	17	5311	1029	CDKN2A
WP710	DNA Damage Response (only ATM dependent)	0.308878186085809	-1.17480829959647	114	1	0.0588235294117647	17	5311	1029	CDKN2A
WP2380	Brain-Derived Neurotrophic Factor (BDNF) signaling pathway	0.373752313494661	-0.984161964344129	144	1	0.0588235294117647	17	5311	2891	GRIA2
WP2377	Integrated Pancreatic Cancer Pathway	0.474580884310777	-0.745323213265765	197	1	0.0588235294117647	17	5311	10468	FST
WP696	Benzo(a)pyrene metabolism	0.999999999994522	-5.47824885465453e-12	9	0	0	17	5311
WP561	Heme Biosynthesis	0.999999999994522	-5.47824885465453e-12	9	0	0	17	5311
WP3297	EV release from cardiac cells and their functional effects	0.999999999994522	-5.47824885465453e-12	9	0	0	17	5311
WP3300	Dual hijack model of Vif in HIV infection	0.999999999994522	-5.47824885465453e-12	9	0	0	17	5311
WP2942	DDX1 as a regulatory component of the Drosha microprocessor	0.999999999994522	-5.47824885465453e-12	9	0	0	17	5311
WP3674	Tgif disruption of Shh signaling	0.999999999994522	-5.47824885465453e-12	9	0	0	17	5311
WP288	NLR Proteins	0.999999999994522	-5.47824885465453e-12	9	0	0	17	5311
WP3585	Cytosine methylation	0.999999999994522	-5.47824885465453e-12	9	0	0	17	5311
WP3875	ATR Signaling	0.999999999994522	-5.47824885465453e-12	9	0	0	17	5311
WP531	Mismatch repair	0.999999999994522	-5.47824885465453e-12	9	0	0	17	5311
WP322	Osteoblast Signaling	0.999999999998056	-1.94367230263268e-12	14	0	0	17	5311
WP2436	Dopamine metabolism	0.999999999998056	-1.94367230263268e-12	14	0	0	17	5311
WP229	Irinotecan Pathway	0.999999999998056	-1.94367230263268e-12	14	0	0	17	5311
WP3853	ERK Pathway in Huntington's Disease	0.999999999998056	-1.94367230263268e-12	14	0	0	17	5311
WP1602	Nicotine Activity on Dopaminergic Neurons	0.999999999998254	-1.74556964531441e-12	21	0	0	17	5311
WP2533	Glycerophospholipid Biosynthetic Pathway	0.999999999998254	-1.74556964531441e-12	21	0	0	17	5311
WP2507	Nanomaterial induced apoptosis	0.999999999998254	-1.74556964531441e-12	21	0	0	17	5311
WP691	Tamoxifen metabolism	0.999999999998254	-1.74556964531441e-12	21	0	0	17	5311
WP3670	Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway	0.999999999998254	-1.74556964531441e-12	21	0	0	17	5311
WP2865	IL1 and megakaryocytes in obesity	1.00000000000087	8.65597122190637e-13	25	0	0	17	5311
WP1528	Physiological and Pathological Hypertrophy  of the Heart	1.00000000000087	8.65597122190637e-13	25	0	0	17	5311
WP3668	Hypothesized Pathways in Pathogenesis of Cardiovascular Disease	1.00000000000087	8.65597122190637e-13	25	0	0	17	5311
WP1971	Integrated Cancer Pathway	1.00000000000102	1.02451048702962e-12	46	0	0	17	5311
WP268	Notch Signaling Pathway	1.00000000000102	1.02451048702962e-12	46	0	0	17	5311
WP3878	ATM Signaling Network in Development and Disease	1.00000000000102	1.02451048702962e-12	46	0	0	17	5311
WP28	Selenium Metabolism and Selenoproteins	1.00000000000102	1.02451048702962e-12	46	0	0	17	5311
WP170	Nuclear Receptors	1.00000000000107	1.06872234377291e-12	39	0	0	17	5311
WP2035	Follicle Stimulating Hormone (FSH) signaling pathway	1.00000000000127	1.26751777792709e-12	27	0	0	17	5311
WP428	Wnt Signaling Pathway	1.00000000000217	2.17136924172695e-12	70	0	0	17	5311
WP2359	Parkin-Ubiquitin Proteasomal System pathway	1.00000000000217	2.17136924172695e-12	70	0	0	17	5311
WP1544	MicroRNAs in cardiomyocyte hypertrophy	1.00000000000236	2.36443790888831e-12	102	0	0	17	5311
WP3529	Zinc homeostasis	1.00000000000255	2.55194000180948e-12	37	0	0	17	5311
WP3414	Initiation of transcription and translation elongation at the HIV-1 LTR	1.00000000000255	2.55194000180948e-12	37	0	0	17	5311
WP619	Type II interferon signaling (IFNG)	1.00000000000255	2.55194000180948e-12	37	0	0	17	5311
WP3614	Photodynamic therapy-induced HIF-1 survival signaling	1.00000000000255	2.55194000180948e-12	37	0	0	17	5311
WP1471	Target Of Rapamycin (TOR) Signaling	1.00000000000255	2.55194000180948e-12	37	0	0	17	5311
WP51	Regulation of Actin Cytoskeleton	1.00000000000281	2.80766363651194e-12	149	0	0	17	5311
WP2536	Colchicine Metabolic Pathway	1.00000000000286	2.86469025584379e-12	1	0	0	17	5311
WP2190	One carbon donor	1.00000000000286	2.86469025584379e-12	1	0	0	17	5311
WP188	Focal Adhesion	1.00000000000286	2.86469025584379e-12	1	0	0	17	5311
WP108	Selenium metabolism/Selenoproteins	1.00000000000286	2.86469025584379e-12	1	0	0	17	5311
WP3191	TSLP Signaling Pathway	1.00000000000286	2.86469025584379e-12	1	0	0	17	5311
WP1	Statin Pathway	1.00000000000286	2.86469025584379e-12	1	0	0	17	5311
WP3627	Gut-Liver Indole Metabolism	1.00000000000286	2.86469025584379e-12	1	0	0	17	5311
WP661	Glucose Homeostasis	1.00000000000286	2.86469025584379e-12	1	0	0	17	5311
WP3865	RIG-I-like Receptor Signaling	1.00000000000305	3.05426208510175e-12	61	0	0	17	5311
WP1530	miRNA Regulation of DNA Damage Response	1.00000000000312	3.12029348190172e-12	93	0	0	17	5311
WP2355	Corticotropin-releasing hormone signaling pathway	1.00000000000312	3.12029348190172e-12	93	0	0	17	5311
WP3925	Amino Acid metabolism	1.00000000000341	3.41302726120788e-12	91	0	0	17	5311
WP69	T-Cell antigen Receptor (TCR)  Signaling Pathway	1.00000000000341	3.41302726120788e-12	91	0	0	17	5311
WP3612	Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling	1.00000000000343	3.43312772193089e-12	23	0	0	17	5311
WP712	Estrogen signaling pathway	1.00000000000343	3.43312772193089e-12	23	0	0	17	5311
WP2371	Parkinsons Disease Pathway	1.0000000000035	3.50235708229463e-12	83	0	0	17	5311
WP1982	Sterol Regulatory Element-Binding Proteins (SREBP) signalling	1.00000000000405	4.04587893990071e-12	73	0	0	17	5311
WP3680	Association Between Physico-Chemical Features and Toxicity Associated Pathways	1.00000000000418	4.17987221424727e-12	68	0	0	17	5311
WP1403	AMP-activated Protein Kinase (AMPK) Signaling	1.00000000000418	4.17987221424727e-12	68	0	0	17	5311
WP2032	Human Thyroid Stimulating Hormone (TSH) signaling pathway	1.00000000000418	4.17987221424727e-12	68	0	0	17	5311
WP3303	Rac1/Pak1/p38/MMP-2 pathway	1.00000000000418	4.17987221424727e-12	68	0	0	17	5311
WP364	IL-6 signaling pathway	1.00000000000421	4.20536321030951e-12	43	0	0	17	5311
WP2911	miRNA targets in ECM and membrane receptors	1.00000000000421	4.20536321030951e-12	43	0	0	17	5311
WP1984	Integrated Breast Cancer Pathway	1.00000000000424	4.23606344373296e-12	154	0	0	17	5311
WP3617	Photodynamic therapy-induced NF-kB survival signaling	1.00000000000464	4.64196812239956e-12	35	0	0	17	5311
WP299	Nuclear Receptors in Lipid Metabolism and Toxicity	1.00000000000464	4.64196812239956e-12	35	0	0	17	5311
WP244	Alpha 6 Beta 4 signaling pathway	1.00000000000464	4.64196812239956e-12	35	0	0	17	5311
WP2868	TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer	1.00000000000476	4.76321758934759e-12	5	0	0	17	5311
WP2542	Sulindac Metabolic Pathway	1.00000000000476	4.76321758934759e-12	5	0	0	17	5311
WP3596	miR-517 relationship with ARCN1 and USP1	1.00000000000476	4.76321758934759e-12	5	0	0	17	5311
WP688	Catalytic cycle of mammalian Flavin-containing MonoOxygenases (FMOs)	1.00000000000476	4.76321758934759e-12	5	0	0	17	5311
WP311	Synthesis and Degradation of Ketone Bodies	1.00000000000476	4.76321758934759e-12	5	0	0	17	5311
WP2597	Secretion of Hydrochloric Acid in Parietal Cells	1.00000000000476	4.76321758934759e-12	5	0	0	17	5311
WP2849	Hematopoietic Stem Cell Differentiation	1.00000000000502	5.02379867640631e-12	48	0	0	17	5311
WP2873	Aryl Hydrocarbon Receptor Pathway	1.00000000000502	5.02379867640631e-12	48	0	0	17	5311
WP2586	Aryl Hydrocarbon Receptor	1.00000000000502	5.02379867640631e-12	48	0	0	17	5311
WP422	MAPK Cascade	1.00000000000562	5.61792182549644e-12	29	0	0	17	5311
WP2583	T-Cell Receptor and Co-stimulatory Signaling	1.00000000000562	5.61792182549644e-12	29	0	0	17	5311
WP2643	Nanoparticle-mediated activation of receptor signaling	1.00000000000562	5.61792182549644e-12	29	0	0	17	5311
WP3613	Photodynamic therapy-induced unfolded protein response	1.00000000000562	5.61792182549644e-12	29	0	0	17	5311
WP1600	Nicotine Metabolism	1.00000000000577	5.76717738312106e-12	6	0	0	17	5311
WP694	Arylamine metabolism	1.00000000000577	5.76717738312106e-12	6	0	0	17	5311
WP3891	Benzene metabolism	1.00000000000577	5.76717738312106e-12	6	0	0	17	5311
WP1981	Thyroxine (Thyroid Hormone) Production	1.00000000000577	5.76717738312106e-12	6	0	0	17	5311
WP3584	MECP2 and Associated Rett Syndrome	1.0000000000058	5.80358879339939e-12	62	0	0	17	5311
WP3863	T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection	1.0000000000058	5.80358879339939e-12	62	0	0	17	5311
WP3646	Hepatitis C and Hepatocellular Carcinoma	1.00000000000586	5.86447156275701e-12	51	0	0	17	5311
WP3851	TLR4 Signaling and Tolerance	1.00000000000596	5.9618778740698e-12	30	0	0	17	5311
WP2870	Extracellular vesicle-mediated signaling in recipient cells	1.00000000000596	5.9618778740698e-12	30	0	0	17	5311
WP129	Matrix Metalloproteinases	1.00000000000596	5.9618778740698e-12	30	0	0	17	5311
WP241	One Carbon Metabolism	1.00000000000596	5.9618778740698e-12	30	0	0	17	5311
WP98	Prostaglandin Synthesis and Regulation	1.00000000000596	5.9618778740698e-12	30	0	0	17	5311
WP3844	PI3K-AKT-mTOR signaling pathway and therapeutic opportunities	1.00000000000596	5.9618778740698e-12	30	0	0	17	5311
WP2855	Dopaminergic Neurogenesis	1.00000000000596	5.9618778740698e-12	30	0	0	17	5311
WP2361	Gastric Cancer Network 1	1.00000000000598	5.9780870907086e-12	28	0	0	17	5311
WP2249	Metastatic brain tumor	1.00000000000598	5.9780870907086e-12	28	0	0	17	5311
WP496	Steroid Biosynthesis	1.00000000000603	6.02863843016771e-12	10	0	0	17	5311
WP2874	Liver X Receptor Pathway	1.00000000000603	6.02863843016771e-12	10	0	0	17	5311
WP704	Methylation Pathways	1.00000000000603	6.02863843016771e-12	10	0	0	17	5311
WP2333	Trans-sulfuration pathway	1.00000000000603	6.02863843016771e-12	10	0	0	17	5311
WP3601	Composition of Lipid Particles	1.00000000000603	6.02863843016771e-12	10	0	0	17	5311
WP3656	Interleukin-1 Induced Activation of NF-kappa-B	1.00000000000603	6.02863843016771e-12	10	0	0	17	5311
WP1531	Vitamin D Metabolism	1.00000000000603	6.02863843016771e-12	10	0	0	17	5311
WP2113	Type III interferon signaling	1.00000000000603	6.02863843016771e-12	10	0	0	17	5311
WP43	Oxidation by Cytochrome P450	1.00000000000609	6.08739718797573e-12	63	0	0	17	5311
WP3624	Lung fibrosis	1.00000000000609	6.08739718797573e-12	63	0	0	17	5311
WP2267	Synaptic Vesicle Pathway	1.00000000000638	6.3751172211778e-12	52	0	0	17	5311
WP430	Statin Pathway	1.0000000000064	6.40254468559466e-12	33	0	0	17	5311
WP2197	Endothelin Pathways	1.0000000000064	6.40254468559466e-12	33	0	0	17	5311
WP453	Inflammatory Response Pathway	1.0000000000064	6.40254468559466e-12	33	0	0	17	5311
WP2363	Gastric Cancer Network 2	1.0000000000064	6.40254468559466e-12	33	0	0	17	5311
WP3676	BDNF-TrkB Signaling	1.0000000000064	6.40254468559466e-12	33	0	0	17	5311
WP58	Monoamine GPCRs	1.0000000000064	6.40254468559466e-12	33	0	0	17	5311
WP236	Adipogenesis	1.00000000000668	6.68340606510191e-12	131	0	0	17	5311
WP138	Androgen receptor signaling pathway	1.00000000000675	6.75010848980626e-12	90	0	0	17	5311
WP477	Cytoplasmic Ribosomal Proteins	1.00000000000675	6.75010848980626e-12	90	0	0	17	5311
WP286	IL-3 Signaling Pathway	1.00000000000682	6.8212470652387e-12	49	0	0	17	5311
WP410	Diurnally Regulated Genes with Circadian Orthologs	1.00000000000682	6.8212470652387e-12	49	0	0	17	5311
WP534	Glycolysis and Gluconeogenesis	1.00000000000682	6.8212470652387e-12	49	0	0	17	5311
WP2646	Lidocaine metabolism	1.00000000000708	7.08179435063197e-12	2	0	0	17	5311
WP1311	Folic Acid Network	1.00000000000708	7.08179435063197e-12	2	0	0	17	5311
WP2866	mir34a and TGIF2 in osteoclastogenesis	1.00000000000708	7.08179435063197e-12	2	0	0	17	5311
WP1273	Folic Acid Network	1.00000000000708	7.08179435063197e-12	2	0	0	17	5311
WP2816	Felbamate Metabolism	1.00000000000708	7.08179435063197e-12	2	0	0	17	5311
WP1438	Influenza A virus infection	1.00000000000708	7.08179435063197e-12	2	0	0	17	5311
WP2366	Butyrate-induced histone acetylation	1.00000000000708	7.08179435063197e-12	2	0	0	17	5311
WP2943	Hypoxia-mediated EMT and Stemness	1.00000000000708	7.08179435063197e-12	2	0	0	17	5311
WP2901	Gonadotropin-releasing hormone (GnRH) signaling	1.00000000000708	7.08179435063197e-12	2	0	0	17	5311
WP536	Calcium Regulation in the Cardiac Cell	1.00000000000729	7.28729238782175e-12	151	0	0	17	5311
WP455	GPCRs, Class A Rhodopsin-like	1.0000000000073	7.29958440564514e-12	259	0	0	17	5311
WP2369	Histone Modifications	1.00000000000748	7.48133160113543e-12	69	0	0	17	5311
WP707	DNA Damage Response	1.00000000000748	7.48133160113543e-12	69	0	0	17	5311
WP35	G Protein Signaling Pathways	1.00000000000757	7.56935422453362e-12	95	0	0	17	5311
WP117	GPCRs, Other	1.00000000000757	7.56935422453362e-12	95	0	0	17	5311
WP3594	Circadian rythm related genes	1.0000000000076	7.60075248561048e-12	207	0	0	17	5311
WP399	Wnt Signaling Pathway and Pluripotency	1.00000000000799	7.99354246801248e-12	106	0	0	17	5311
WP2203	Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway	1.0000000000082	8.20018104023153e-12	47	0	0	17	5311
WP1310	Selenium Micronutrient Network	1.00000000000841	8.40969729968805e-12	7	0	0	17	5311
WP3595	mir-124 predicted interactions with cell cycle and differentiation	1.00000000000841	8.40969729968805e-12	7	0	0	17	5311
WP2596	Gastric acid production	1.00000000000841	8.40969729968805e-12	7	0	0	17	5311
WP1272	Selenium Micronutrient Network	1.00000000000841	8.40969729968805e-12	7	0	0	17	5311
WP528	Acetylcholine Synthesis	1.00000000000841	8.40969729968805e-12	7	0	0	17	5311
WP2805	RNA interference	1.00000000000841	8.40969729968805e-12	7	0	0	17	5311
WP3924	Hfe effect on hepcidin production	1.00000000000841	8.40969729968805e-12	7	0	0	17	5311
WP134	Pentose Phosphate Pathway	1.00000000000841	8.40969729968805e-12	7	0	0	17	5311
WP699	Aflatoxin B1 metabolism	1.00000000000841	8.40969729968805e-12	7	0	0	17	5311
WP678	Arachidonate Epoxygenase / Epoxide Hydrolase	1.00000000000841	8.40969729968805e-12	7	0	0	17	5311
WP438	Non-homologous end joining	1.00000000000841	8.40969729968805e-12	7	0	0	17	5311
WP1995	Effects of Nitric Oxide	1.00000000000841	8.40969729968805e-12	7	0	0	17	5311
WP231	TNF alpha Signaling Pathway	1.00000000000852	8.52241444191902e-12	94	0	0	17	5311
WP2795	Cardiac Hypertrophic Response	1.00000000000861	8.61273851311559e-12	57	0	0	17	5311
WP195	IL-1 signaling pathway	1.00000000000861	8.61273851311559e-12	57	0	0	17	5311
WP304	Kit receptor signaling pathway	1.00000000000872	8.7182811197238e-12	60	0	0	17	5311
WP558	Complement and Coagulation Cascades	1.00000000000872	8.7182811197238e-12	60	0	0	17	5311
WP3527	Preimplantation Embryo	1.00000000000872	8.7182811197238e-12	60	0	0	17	5311
WP2011	SREBF and miR33 in cholesterol and lipid homeostasis	1.00000000000878	8.78212542905241e-12	19	0	0	17	5311
WP22	IL-9 Signaling Pathway	1.00000000000878	8.78212542905241e-12	19	0	0	17	5311
WP1992	TarBasePathway	1.00000000000878	8.78212542905241e-12	19	0	0	17	5311
WP247	Small Ligand GPCRs	1.00000000000878	8.78212542905241e-12	19	0	0	17	5311
WP3287	Overview of nanoparticle effects	1.00000000000878	8.78212542905241e-12	19	0	0	17	5311
WP697	Estrogen metabolism	1.00000000000878	8.78212542905241e-12	19	0	0	17	5311
WP384	Apoptosis Modulation by HSP70	1.00000000000878	8.78212542905241e-12	19	0	0	17	5311
WP404	Nucleotide Metabolism	1.00000000000878	8.78212542905241e-12	19	0	0	17	5311
WP3877	Simplified Depiction of MYD88 Distinct Input-Output Pathway	1.00000000000878	8.78212542905241e-12	19	0	0	17	5311
WP734	Serotonin Receptor 4/6/7 and NR3C Signaling	1.00000000000878	8.78212542905241e-12	19	0	0	17	5311
WP2879	Farnesoid X Receptor  Pathway	1.00000000000878	8.78212542905241e-12	19	0	0	17	5311
WP897	Androgen receptor signaling pathway	1.00000000000886	8.864724080521e-12	4	0	0	17	5311
WP733	Serotonin Receptor 2 and STAT3 Signaling	1.00000000000886	8.864724080521e-12	4	0	0	17	5311
WP3302	eIF5A regulation in response to inhibition of the nuclear export system	1.00000000000886	8.864724080521e-12	4	0	0	17	5311
WP3633	Caffeine and Theobromine metabolism	1.00000000000886	8.864724080521e-12	4	0	0	17	5311
WP2889	Oxytocin signaling	1.00000000000886	8.864724080521e-12	4	0	0	17	5311
WP2491	Diclofenac Metabolic Pathway	1.00000000000886	8.864724080521e-12	4	0	0	17	5311
WP1133	Androgen receptor signaling pathway	1.00000000000886	8.864724080521e-12	4	0	0	17	5311
WP1941	Peroxisomal beta-oxidation of tetracosanoyl-CoA	1.00000000000886	8.864724080521e-12	4	0	0	17	5311
WP2253	Pilocytic astrocytoma	1.00000000000886	8.864724080521e-12	4	0	0	17	5311
WP1603	Nicotine Activity on Chromaffin Cells	1.00000000000886	8.864724080521e-12	4	0	0	17	5311
WP690	Polyol Pathway	1.00000000000886	8.864724080521e-12	4	0	0	17	5311
WP521	Amino acid conjugation of benzoic acid	1.00000000000886	8.864724080521e-12	4	0	0	17	5311
WP391	Mitochondrial Gene Expression	1.00000000000897	8.96894497094828e-12	20	0	0	17	5311
WP1422	Sphingolipid Metabolism	1.00000000000897	8.96894497094828e-12	20	0	0	17	5311
WP497	Urea cycle and metabolism of amino groups	1.00000000000897	8.96894497094828e-12	20	0	0	17	5311
WP516	Hypertrophy Model	1.00000000000897	8.96894497094828e-12	20	0	0	17	5311
WP732	Serotonin Receptor 2 and ELK-SRF/GATA4 signaling	1.00000000000897	8.96894497094828e-12	20	0	0	17	5311
WP2509	Nanoparticle triggered autophagic cell death	1.00000000000898	8.98104179741897e-12	24	0	0	17	5311
WP1539	Angiogenesis	1.00000000000898	8.98104179741897e-12	24	0	0	17	5311
WP262	EBV LMP1 signaling	1.00000000000898	8.98104179741897e-12	24	0	0	17	5311
WP3658	Wnt/beta-catenin Signaling Pathway in Leukemia	1.00000000000898	8.98104179741897e-12	24	0	0	17	5311
WP334	GPCRs, Class B Secretin-like	1.00000000000898	8.98104179741897e-12	24	0	0	17	5311
WP2435	Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis	1.0000000000092	9.20136107197224e-12	15	0	0	17	5311
WP197	Cholesterol Biosynthesis	1.0000000000092	9.20136107197224e-12	15	0	0	17	5311
WP3	Transcriptional activation by NRF2	1.0000000000092	9.20136107197224e-12	15	0	0	17	5311
WP206	Fatty Acid Omega Oxidation	1.0000000000092	9.20136107197224e-12	15	0	0	17	5311
WP2332	Interleukin-11 Signaling Pathway	1.00000000000931	9.30523303540077e-12	44	0	0	17	5311
WP314	Fas Ligand (FasL) pathway and Stress induction of Heat Shock Proteins (HSP) regulation	1.00000000000931	9.30523303540077e-12	44	0	0	17	5311
WP716	Vitamin A and Carotenoid Metabolism	1.00000000000931	9.30523303540077e-12	44	0	0	17	5311
WP706	Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways	1.00000000000949	9.49315034510291e-12	162	0	0	17	5311
WP437	EGF/EGFR Signaling Pathway	1.00000000000949	9.49315034510291e-12	162	0	0	17	5311
WP2059	Alzheimers Disease	1.00000000000957	9.5712571161105e-12	148	0	0	17	5311
WP23	B Cell Receptor Signaling Pathway	1.00000000000965	9.65018214502991e-12	98	0	0	17	5311
WP2875	Constitutive Androstane Receptor Pathway	1.00000000001012	1.01219592462958e-11	32	0	0	17	5311
WP727	Monoamine Transport	1.00000000001012	1.01219592462958e-11	32	0	0	17	5311
WP2525	Trans-sulfuration and one carbon metabolism	1.00000000001012	1.01219592462958e-11	32	0	0	17	5311
WP3858	Toll-like Receptor Signaling	1.00000000001012	1.01219592462958e-11	32	0	0	17	5311
WP524	G13 Signaling Pathway	1.00000000001023	1.0230879856621e-11	40	0	0	17	5311
WP2516	ATM Signaling Pathway	1.00000000001023	1.0230879856621e-11	40	0	0	17	5311
WP127	IL-5 Signaling Pathway	1.00000000001023	1.0230879856621e-11	40	0	0	17	5311
WP75	Toll-like Receptor Signaling Pathway	1.00000000001032	1.03214919677476e-11	103	0	0	17	5311
WP185	Integrin-mediated Cell Adhesion	1.00000000001032	1.03214919677476e-11	103	0	0	17	5311
WP2034	Leptin signaling pathway	1.00000000001036	1.03571554575125e-11	76	0	0	17	5311
WP2118	Arrhythmogenic Right Ventricular Cardiomyopathy	1.00000000001036	1.03571554575125e-11	76	0	0	17	5311
WP2037	Prolactin Signaling Pathway	1.00000000001036	1.03571554575125e-11	76	0	0	17	5311
WP306	Focal Adhesion	1.00000000001047	1.04721174483405e-11	195	0	0	17	5311
WP3664	Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds	1.00000000001052	1.05228144385981e-11	18	0	0	17	5311
WP3859	TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition	1.00000000001052	1.05228144385981e-11	18	0	0	17	5311
WP3413	NOTCH1 regulation of human endothelial cell calcification	1.00000000001052	1.05228144385981e-11	18	0	0	17	5311
WP692	Sulfation Biotransformation Reaction	1.00000000001052	1.05228144385981e-11	18	0	0	17	5311
WP3879	4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression	1.00000000001052	1.05228144385981e-11	18	0	0	17	5311
WP78	TCA Cycle	1.00000000001063	1.06323332795809e-11	17	0	0	17	5311
WP2916	Interactome of polycomb repressive complex 2 (PRC2)	1.00000000001063	1.06323332795809e-11	17	0	0	17	5311
WP3874	Canonical and Non-Canonical TGF-B signaling	1.00000000001063	1.06323332795809e-11	17	0	0	17	5311
WP3678	Amplification and Expansion of Oncogenic Pathways as Metastatic Traits	1.00000000001063	1.06323332795809e-11	17	0	0	17	5311
WP368	Mitochondrial LC-Fatty Acid Beta-Oxidation	1.00000000001063	1.06323332795809e-11	17	0	0	17	5311
WP2289	Drug Induction of Bile Acid Pathway	1.00000000001063	1.06323332795809e-11	17	0	0	17	5311
WP554	ACE Inhibitor Pathway	1.00000000001063	1.06323332795809e-11	17	0	0	17	5311
WP382	MAPK Signaling Pathway	1.00000000001067	1.06693132268711e-11	170	0	0	17	5311
WP466	DNA Replication	1.00000000001076	1.07589554599963e-11	42	0	0	17	5311
WP2036	TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway	1.00000000001076	1.07589554599963e-11	42	0	0	17	5311
WP405	Eukaryotic Transcription Initiation	1.00000000001076	1.07589554599963e-11	42	0	0	17	5311
WP49	IL-2 Signaling Pathway	1.00000000001076	1.07589554599963e-11	42	0	0	17	5311
WP2324	AGE/RAGE pathway	1.00000000001076	1.07638110791973e-11	66	0	0	17	5311
WP3651	Pathways Affected in Adenoid Cystic Carcinoma	1.00000000001076	1.07638110791973e-11	66	0	0	17	5311
WP183	Proteasome Degradation	1.00000000001076	1.07638110791973e-11	66	0	0	17	5311
WP2374	Oncostatin M Signaling Pathway	1.00000000001076	1.07638110791973e-11	66	0	0	17	5311
WP3892	Development of pulmonary dendritic cells and macrophage subsets	1.00000000001097	1.0965414916484e-11	13	0	0	17	5311
WP186	Homologous recombination	1.00000000001097	1.0965414916484e-11	13	0	0	17	5311
WP1434	Osteopontin Signaling	1.00000000001097	1.0965414916484e-11	13	0	0	17	5311
WP3871	Valproic acid pathway	1.00000000001097	1.0965414916484e-11	13	0	0	17	5311
WP3679	Cell-type Dependent Selectivity of CCK2R Signaling	1.00000000001097	1.0965414916484e-11	13	0	0	17	5311
WP1991	SRF and miRs in Smooth Muscle Differentiation and Proliferation	1.00000000001097	1.0965414916484e-11	13	0	0	17	5311
WP2881	Estrogen Receptor Pathway	1.00000000001097	1.0965414916484e-11	13	0	0	17	5311
WP3876	BMP2-WNT4-FOXO1 Pathway in Human Primary Endometrial Stromal Cell Differentiation	1.00000000001097	1.0965414916484e-11	13	0	0	17	5311
WP1423	Ganglio Sphingolipid Metabolism	1.00000000001097	1.0965414916484e-11	13	0	0	17	5311
WP366	TGF-beta Signaling Pathway	1.00000000001103	1.10328345339731e-11	133	0	0	17	5311
WP289	Myometrial Relaxation and Contraction Pathways	1.00000000001108	1.10760854205257e-11	158	0	0	17	5311
WP107	Translation Factors	1.0000000000112	1.11958922853693e-11	53	0	0	17	5311
WP363	Wnt Signaling Pathway Netpath	1.0000000000112	1.11958922853693e-11	53	0	0	17	5311
WP2406	Cardiac Progenitor Differentiation	1.0000000000112	1.11958922853693e-11	53	0	0	17	5311
WP1449	Regulation of toll-like receptor signaling pathway	1.00000000001131	1.13089744489401e-11	145	0	0	17	5311
WP3915	Angiopoietin Like Protein 8 Regulatory Pathway	1.00000000001136	1.13579612720221e-11	132	0	0	17	5311
WP411	mRNA Processing	1.00000000001136	1.13579612720221e-11	132	0	0	17	5311
WP383	Striated Muscle Contraction	1.00000000001152	1.15239759549152e-11	38	0	0	17	5311
WP2029	Cell Differentiation - Index	1.00000000001152	1.15239759549152e-11	38	0	0	17	5311
WP2526	PDGF Pathway	1.00000000001152	1.15239759549152e-11	38	0	0	17	5311
WP2447	Amyotrophic lateral sclerosis (ALS)	1.00000000001152	1.15239759549152e-11	38	0	0	17	5311
WP481	Insulin Signaling	1.00000000001154	1.15407681625037e-11	161	0	0	17	5311
WP2453	TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc)	1.00000000001164	1.16405466268785e-11	16	0	0	17	5311
WP12	Osteoclast Signaling	1.00000000001164	1.16405466268785e-11	16	0	0	17	5311
WP53	ID signaling pathway	1.00000000001164	1.16405466268785e-11	16	0	0	17	5311
WP550	Biogenic Amine Synthesis	1.00000000001164	1.16405466268785e-11	16	0	0	17	5311
WP501	GPCRs, Class C Metabotropic glutamate, pheromone	1.00000000001164	1.16405466268785e-11	16	0	0	17	5311
WP3644	NAD+ metabolism	1.00000000001164	1.16405466268785e-11	16	0	0	17	5311
WP47	Hedgehog Signaling Pathway	1.00000000001164	1.16405466268785e-11	16	0	0	17	5311
WP1946	Cori Cycle	1.00000000001164	1.16405466268785e-11	16	0	0	17	5311
WP2291	Deregulation of Rab and Rab Effector Genes in Bladder Cancer	1.00000000001164	1.16405466268785e-11	16	0	0	17	5311
WP2637	Structural Pathway of Interleukin 1 (IL-1)	1.00000000001173	1.17272519417189e-11	50	0	0	17	5311
WP1545	miRNAs involved in DNA damage response	1.00000000001173	1.17272519417189e-11	50	0	0	17	5311
WP408	Oxidative Stress	1.00000000001174	1.17368089339864e-11	31	0	0	17	5311
WP2112	IL17 signaling pathway	1.00000000001174	1.17368089339864e-11	31	0	0	17	5311
WP3850	Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling	1.00000000001174	1.17368089339864e-11	31	0	0	17	5311
WP3630	NAD metabolism, sirtuins and aging	1.00000000001181	1.18089519423572e-11	11	0	0	17	5311
WP2513	Nanoparticle triggered regulated necrosis	1.00000000001181	1.18089519423572e-11	11	0	0	17	5311
WP1455	Serotonin Transporter Activity	1.00000000001181	1.18089519423572e-11	11	0	0	17	5311
WP2854	Gene regulatory network modelling somitogenesis	1.00000000001181	1.18089519423572e-11	11	0	0	17	5311
WP80	Nucleotide GPCRs	1.00000000001181	1.18089519423572e-11	11	0	0	17	5311
WP500	Glycogen Metabolism	1.00000000001211	1.21070809452593e-11	36	0	0	17	5311
WP3298	Melatonin metabolism and effects	1.00000000001211	1.21070809452593e-11	36	0	0	17	5311
WP2012	miRs in Muscle Cell Differentiation	1.00000000001211	1.21070809452593e-11	36	0	0	17	5311
WP111	Electron Transport Chain	1.00000000001244	1.2441906959811e-11	92	0	0	17	5311
WP474	Endochondral Ossification	1.00000000001254	1.25424877938808e-11	65	0	0	17	5311
WP702	Metapathway biotransformation	1.00000000001291	1.29080277136196e-11	177	0	0	17	5311
WP698	Glucuronidation	1.00000000001347	1.34664197741603e-11	26	0	0	17	5311
WP2878	PPAR Alpha Pathway	1.00000000001347	1.34664197741603e-11	26	0	0	17	5311
WP581	EPO Receptor Signaling	1.00000000001347	1.34664197741603e-11	26	0	0	17	5311
WP26	Signal Transduction of S1P Receptor	1.00000000001347	1.34664197741603e-11	26	0	0	17	5311
WP325	Triacylglyceride Synthesis	1.00000000001347	1.34664197741603e-11	26	0	0	17	5311
WP143	Fatty Acid Beta Oxidation	1.00000000001359	1.35906580717913e-11	34	0	0	17	5311
WP1601	Fluoropyrimidine Activity	1.00000000001359	1.35906580717913e-11	34	0	0	17	5311
WP400	p38 MAPK Signaling Pathway	1.00000000001359	1.35906580717913e-11	34	0	0	17	5311
WP313	Signaling of Hepatocyte Growth Factor Receptor	1.00000000001359	1.35906580717913e-11	34	0	0	17	5311
WP24	Peptide GPCRs	1.00000000001417	1.41733594674799e-11	74	0	0	17	5311
WP1433	Nucleotide-binding Oligomerization Domain (NOD) pathway	1.00000000001428	1.428249124705e-11	41	0	0	17	5311
WP673	ErbB Signaling Pathway	1.00000000001509	1.50883037827471e-11	54	0	0	17	5311
WP623	Oxidative phosphorylation	1.00000000001509	1.50883037827471e-11	54	0	0	17	5311
WP2864	Apoptosis-related network due to altered Notch3 in ovarian cancer	1.00000000001509	1.50883037827471e-11	54	0	0	17	5311
WP3286	Copper homeostasis	1.00000000001509	1.50883037827471e-11	54	0	0	17	5311
WP395	IL-4 Signaling Pathway	1.00000000001513	1.51341150008257e-11	55	0	0	17	5311
WP2018	RANKL/RANK (Receptor activator of NFKB (ligand)) Signaling Pathway	1.00000000001513	1.51341150008257e-11	55	0	0	17	5311
WP585	Interferon type I signaling pathways	1.00000000001513	1.51341150008257e-11	55	0	0	17	5311
WP2276	Glial Cell Differentiation	1.0000000000154	1.53958467443157e-11	8	0	0	17	5311
WP3634	Insulin signalling in human adipocytes (normal condition)	1.0000000000154	1.53958467443157e-11	8	0	0	17	5311
WP2338	miRNA Biogenesis	1.0000000000154	1.53958467443157e-11	8	0	0	17	5311
WP237	Glucocorticoid &amp; Mineralcorticoid Metabolism	1.0000000000154	1.53958467443157e-11	8	0	0	17	5311
WP3655	Hypothetical Craniofacial Development Pathway	1.0000000000154	1.53958467443157e-11	8	0	0	17	5311
WP3407	FTO Obesity Variant Mechanism	1.0000000000154	1.53958467443157e-11	8	0	0	17	5311
WP1589	Folate-Alcohol and Cancer Pathway	1.0000000000154	1.53958467443157e-11	8	0	0	17	5311
WP1604	Codeine and Morphine Metabolism	1.0000000000154	1.53958467443157e-11	8	0	0	17	5311
WP3635	Insulin signalling in human adipocytes (diabetic condition)	1.0000000000154	1.53958467443157e-11	8	0	0	17	5311
WP136	Phase I biotransformations, non P450	1.0000000000154	1.53958467443157e-11	8	0	0	17	5311
WP2846	Proprotein convertase subtilisin/kexin type 9 (PCSK9) mediated LDL receptor degradation	1.00000000001547	1.54665843155375e-11	3	0	0	17	5311
WP3408	Evolocumab Mechanism	1.00000000001547	1.54665843155375e-11	3	0	0	17	5311
WP2431	Spinal Cord Injury	1.00000000001552	1.55225430301772e-11	119	0	0	17	5311
WP2446	Retinoblastoma (RB) in Cancer	1.00000000001696	1.69555391047775e-11	88	0	0	17	5311
WP2328	Allograft Rejection	1.00000000001722	1.72208993021744e-11	80	0	0	17	5311
WP167	Eicosanoid Synthesis	1.00000000001916	1.9161947400552e-11	22	0	0	17	5311
WP3657	Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex	1.00000000001916	1.9161947400552e-11	22	0	0	17	5311
WP3645	NAD+ biosynthetic pathways	1.00000000001916	1.9161947400552e-11	22	0	0	17	5311
WP1424	Globo Sphingolipid Metabolism	1.00000000001916	1.9161947400552e-11	22	0	0	17	5311
WP3872	Regulation of Apoptosis by Parathyroid Hormone-related Protein	1.00000000001916	1.9161947400552e-11	22	0	0	17	5311
WP545	Complement Activation	1.00000000001916	1.9161947400552e-11	22	0	0	17	5311
WP357	Fatty Acid Biosynthesis	1.00000000001916	1.9161947400552e-11	22	0	0	17	5311
WP3599	Transcription factor regulation in adipogenesis	1.00000000001916	1.9161947400552e-11	22	0	0	17	5311
WP1584	Type II diabetes mellitus	1.00000000001916	1.9161947400552e-11	22	0	0	17	5311
WP100	Glutathione metabolism	1.00000000001916	1.9161947400552e-11	22	0	0	17	5311
WP272	Blood Clotting Cascade	1.00000000001916	1.9161947400552e-11	22	0	0	17	5311
WP2290	RalA downstream regulated genes	1.00000000002195	2.19532753100251e-11	12	0	0	17	5311
WP2007	Iron metabolism in placenta	1.00000000002195	2.19532753100251e-11	12	0	0	17	5311
WP3849	MAPK  and NFkB Signalling Pathways Inhibited by Yersinia YopJ	1.00000000002195	2.19532753100251e-11	12	0	0	17	5311
WP3301	MFAP5-mediated ovarian cancer cell motility and invasiveness	1.00000000002195	2.19532753100251e-11	12	0	0	17	5311
WP1559	TFs Regulate miRNAs related to cardiac hypertrophy	1.00000000002195	2.19532753100251e-11	12	0	0	17	5311
WP106	Alanine and aspartate metabolism	1.00000000002195	2.19532753100251e-11	12	0	0	17	5311
WP3672	LncRNA-mediated mechanisms of therapeutic resistance	1.00000000002195	2.19532753100251e-11	12	0	0	17	5311
